The characterisation of flavone-DNA isoform interactions as a basis for anticancer drug development

Anticancer Research

Volumn 29, Issue 6, 2009, Pages 2273-2283

  Ragazzon, Patricia A ^a,c   Bradshaw, Tracey ^b   Matthews, Charlie ^b   Iley, Jim ^a   Missailidis, Sotiris ^a  

^a OPEN UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c CXR Biosciences Ltd   (United Kingdom)

Author keywords

Cancer cell lines; DNA binding; Flavonoids; Fluorescence spectroscopy; Polynucleotides; Quadruplex DNA; Triplex DNA; UV

Indexed keywords

BAICALEIN; BAICALIN; DAIDZEIN; DNA; DOUBLE STRANDED DNA; FLAVONE DERIVATIVE; METAL ION; PUERARIN; QUERCETIN; RUTOSIDE;

ANALYTIC METHOD; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; BREAST CANCER; CANCER CELL; COMET ASSAY; COMPETITION DIALYSIS; CONTROLLED STUDY; DRUG DNA BINDING; DRUG DNA INTERACTION; FLOW CYTOMETRY; FLUORESCENCE SPECTROSCOPY; HUMAN; HUMAN CELL; LEUKEMIA CELL; NUCLEIC ACID STRUCTURE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; ULTRAVIOLET SPECTROSCOPY;

BREAST NEOPLASMS; CELL PROLIFERATION; COMET ASSAY; DNA; FEMALE; FLAVONES; FLOW CYTOMETRY; G-QUADRUPLEXES; HUMANS; NUCLEIC ACID CONFORMATION; SPECTROPHOTOMETRY, ULTRAVIOLET; TUMOR CELLS, CULTURED;

EID: 67650904960     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Jenkins T: Targeting multi-stranded DNA structures. Curr Med Chem 7: 99-115, 2000.
2. Horn V, Lacroix L, Gautier T, Takasugi M, Mergny J and, Lacoste J: Triple helix formation with Drosophila satellite repeats. Unexpected stabilization by copper ions. Biochemistry 43: 11196-11205, 2004.
3. Neidle S and Parkinson G: Telomere maintenance as a target for anticancer drug discovery. Nat Rev Drug Design 1: 383-393, 2002. (Pubitemid 37361468)
4. Li P, Lam E, Roos W, Zdzienicka M, Kaina B and Efferth T: Artesunate derived from traditional Chinese medicine induces DNA damage and repair. Cancer Res 686: 4347-4351, 2008.
5. Ikemoto S, Sugimura K, Yoshida N, Yasumoto R, Wada S, Yamamoto K and Kishimoto T: Antitumor effects of Scutellariae radix and its components baicalein, baicalin, and wogonin on bladder cancer cell lines. Urology 55: 951-955, 2000.
6. Chan H, Chen Z, Tsang D and Leung L: Baicalein inhibits DMBA-DNA adduct formation by modulating CYP1A1 and CYP1B1. Biomed Pharmacol 56: 269-275, 2002.
7. Rossi M, Meyer R, Constantinou P, Caruso F, Castelbuono D, O'Brien M and Narasimhan V: Molecular structure and activity toward DNA, baicalin a flavone constituent of the Asian herbal medicine Sho-saiko-to. J Nat Prod 64: 26-31, 2001. (Pubitemid 32107772)
8. Chao J, Su W and Liu H: Baicalein induces cancer cell death and proliferation retardation by the inhibition of CDC2 kinase and survivin associated with opposite role of p38 mitogen-activated protein kinase and AKT. Molec Cancer Ther 6: 1039-1048, 2007. (Pubitemid 350206782)
9. Dreiseitel A, Schreier P, Oehme A, Locher S, Rogler G, Piberger H, Hajak G and Sand P: Inhibition of proteasome activity by anthocyanins and anthocyanidins. Biochem Biophys Res Commun 372: 57-61, 2008.
10. Watanabe S and Uesugi S: Isoflavones for prevention of cancer, cardiovascular diseases, gynaecological problems and possible immune potentiation. Biomed Pharmacol 56: 302-312, 2002. (Pubitemid 35245314)
11. Pugazhendhi D, Watson K, Mills S, Botting N, Pope G and Darbre P: Effect of sulphation on the oestrogen agonist activity of the phytoestrogens genistein and daidzein in MCF-7 human breast cancer cells. J Endocrinol 197: 503-515, 2008. (Pubitemid 351803955)
12. Cantero G, Campanella C, Mateos S and Cortés F: Bioflavonoids as poisons of human topoisomerase II alpha and II beta. Biochemistry 46: 6097-6108, 2006.
13. Guo Q, Rimbach G and Moini H: ESR and cell culture studies on free radical scavenging and antioxidant activities of isoflavonoids. Toxicology 79: 171-180, 2002. (Pubitemid 35245473)
14. Fu-Liang X, Xiao-Hui S, Lu G, Xiang-Liang Y and Hui-Bi X: Puerarin protects rat pancreatic islets from damage by hydrogen peroxide. Eur J Pharm 529: 1-7, 2005
15. Yu Z and Li W: Induction of apoptosis by puerarin in colon cancer HT-29 cells. Cancer Lett 238: 53-60, 2006. (Pubitemid 43851146)
16. Boots A, Haenen G and Bast A: Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 585: 325-337, 2008.
17. La Casa C and Villegas I: Evidence for protective and antioxidant properties of rutin, a natural flavone, against ethanol induced gastric lesions. J Ethnopharmacol 71: 45-53, 2000. (Pubitemid 30440651)
18. 2/M arrest and inducing apoptosis. Food Chem Toxicol 46: 2042-2053, 2008.
19. Sun H, Tang Y, Xiang J, Xu G, Zhang Y, Zhang H and Xu L: Spectroscopic studies of the interaction between quercetin and G-quadruplex DNA. Bioorg Med Chem Lett 16: 3586-13585, 2006. (Pubitemid 43777091)
20. Wang W, Jia Z, Yao S, Fan B and Zheng R: Fast repair of purine deoxynucleotide radical cations by rutin and quercetin. Sci in China 64: 610-617, 2001. (Pubitemid 33768018)
21. Peñarrieta J, Alvarado J, Akesson B and Bergenståhl B: Total antioxidant capacity and content of flavonoids and other phenolic compounds in canihua (Chenopodium pallidicaule): an Andean pseudocereal. Mol Nutr Food Res 52: 708-717, 2008.
22. Zhu A, Can L and Li NQ: Eletrochemical studies of quercetin interacting with DNA Microchemical J 71: 57-63, 2002.
23. Ragazzon P and Chaires J: Use of competition dialysis in the discovery of G-quadruplex selective ligands. Methods 43: 313-323, 2007. (Pubitemid 47633211)
24. Jenkins T: Drug-DNA Interaction Protocols. In: Methods in Molecular Biology. Fox K (eds.). New Jersey, Humana Press, pp. 204-213, 1997.
25. Cheng M, Modi C, Cookson J, Hutchinson I, Heald R, McCarroll A, Missailidis S, Tanious F, Wilson W, Mergny J, Laughton C and Stevens M: Antitumor polycyclic acridines. 20. Search for DNA quadruplex binding selectivity in a series of 8,13-dimethylquino[4,3,2-kl]acridinium salts: telomere-targeted agents. J Med Chem 51: 963-975, 2008.
26. Antonini I: Rational design, synthesis and biological evaluation of thiadiazinoacridines: A new class of antitumor agents. Bioorg Medicin Chem 11: 399-405, 2003. (Pubitemid 36051030)
27. Mills M, Arimondo P, Lacroix L, Garestier T, Hélène C, Klump HH and Mergny JL: Energetics of strand-displacement reactions in triple helices: a spectroscopic study. J Mol Biol 291:1035-1054, 1999 (Pubitemid 29423768)
28. Mergny J and Riou J: Natural and pharmacological regulation of telomerase.Nucleic Acids Res 30: 39-865, 2002.
29. Mills M, Lacroix L, Arimondo P, Leroy J, François J, Klump H and Mergny J: Unusual DNA conformations: implications for telomeres. Curr Med Chem Anticancer Agents 2: 627-644, 2002. (Pubitemid 34874062)
30. Jenkins T and Perry P: DNA tetraplex-binding drugs structure-selective targeting is critical for antitumour telomerase inhibition. Mini Rev Med Chem 1: 31-41, 2001.
31. Wang Y and Patel DJ: Solution structure of the human telomeric repeat d[AG3(T2AG3)3] G-tetraplex. Structure 1: 263-282, 1993.
32. Yamashita N, Tanemura H and Kawanishi S: Mechanism of oxidative DNA damage induced by quercetin in the presence of Cu II. Mutat Res 425: 107-115, 1999. (Pubitemid 29122033)
33. Gandori R, Schwarzinger S and Müller N: Cloning, overexpression and characterization of micro-myoglobin, a minimal heme-binding fragment. Eur J Biochem 267: 1168-1172, 2000. (Pubitemid 30108336)
34. Lambert L, Perri H, Halbrooks P and Mason A: Evolution of the transferring family: conservation of residues associated with iron and anion binding. Comp Biochem Physiol Part B: Biochem and Mol Biol 142: 129-141, 2005. (Pubitemid 41262552)
35. Asadi M, Safaei E and Ranjbar B: A study on the binding of two water-soluble tetrapyridinoporphyrazinato copper (II) complexes to DNA. J Mol Strut 754: 116-123, 2005. (Pubitemid 41534631)
36. Mooren F, Golf S and Lechterman A: Alterations of ionized Mg (II) in human blood after exercise. Life Sci 77: 1211-1225, 2005. (Pubitemid 40898321)
37. Touyz R and Yao G: Modulation of vascular smooth muscle cell growth by magnesium - role of mitogen-activated protein. J Cell Physiol 197: 326-335, 2003. (Pubitemid 37487031)
38. Sepp A and Choo Y: Cell-free selection of zinc finger DNA-binding protein using in vitro compartmentalization. J Mol Biol 354: 212-219, 2005.
39. Pierpont CG and Lange CW: The chemistry of transition metal complexes containing catechol and semiquinone ligands. In: Progress in Inorganic Chemistry Karlin KD (ed.). New York, John Wiley & Sons, pp. 331-442, 1994.
40. 2/M cell cycle arrest. Mol Cancer 5: 76-84, 2006. (Pubitemid 46189684)
41. Haddad AQ, Venateswaran V, Viswanathan L, Teahan SJ, Fleshner NE and Klotz LH: Novel antiproliferative flavonoids induce cell cycle arrest in human prostate cancer cell lines. Prostate Cancer Prostatic Dis 9: 68-76, 2006. (Pubitemid 43378873)
42. Bayer T, Colnot T and Dekant J: Disposition and biotransformation of the estrogenic isoflavone daidzein in rats. Toxicol Sci 61: 205-211, 2001. (Pubitemid 32707734)
43. Czyz M, Szulawaska A and Bednarek A: Effects of anthracycline derivatives on human leukemia K562 cell growth and differentiation. Biochem Pharmacol 70: 1431-1442, 2005. (Pubitemid 41483454)
44. De Vincenzo R, Ferlini C, Distefano M, Gaggini C, Riva A, Bombardelli E, Morazzoni P, Valenti P, Belluti F, Ranelletti FO, Mancuso S and Scambia G: In vitro evaluation of newly developed chalcone analogues in human cancer cells. Cancer Chemother Pharmacol 46: 305-316, 2000.